Quality of life and climacteric symptoms in post-menopausal women receiving hormone therapy for breast cancer
2020
Abstract Objective To assess quality of life and climacteric symptoms for post-menopausal women receiving hormone therapy for breast cancer. Methods A prospective observational study of women treated at the Mastology Outpatient Clinic of the Department of Obstetrics and Gynecology was conducted between 2015 and 2019. Post-menopausal patients who had been diagnosed with breast cancer, and who were experience climacteric symptoms were selected. These patients had undergone surgery, radiotherapy, and/or chemotherapy more than one year prior and were receiving tamoxifen or an aromatase inhibitor. A total of 57 women were recruited and during visits completed a sociodemographic questionnaire, the Blatt-Kupperman Menopausal Index (KI), and the World Health Organization Quality of Life version-bref (WHOQOL-bref) scale. Repeated measures ANOVA, and Friedman and Pearson tests were conducted. Results Patients had a mean age of 54.4 ±5.9 years, 86% had ductal carcinoma, 98% had undergone surgery, 70% had received chemotherapy and 96% had received radiotherapy. Scores on the KI (P Conclusions The correlation of the scales showed that reduction in climacteric symptoms is associated with significant improvements in quality of life measures.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
0
Citations
NaN
KQI